These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 352850)

  • 1. [Results of experimental and clinical studies of a new antileukemic drug: hexaphosphamide. Review of the literature and the author's own results].
    Khomchenovskii EI
    Haematologia (Budap); 1977; 11(1-2):115-26. PubMed ID: 352850
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of hexaphosphamide for the treatment of myelocytic leukemia].
    Nevskaia TP; Levitin EI; Mokeeva RA; Faĭnshteĭn FE
    Probl Gematol Pereliv Krovi; 1976 Jul; 21(7):57. PubMed ID: 1071794
    [No Abstract]   [Full Text] [Related]  

  • 3. [Status of plasma blood clotting factors during different stages of erythromyelosis in rats and the effect of hexaphosphamide on the indices studied].
    Stepanian MA; Chilingarian AG; Muradian LB
    Zh Eksp Klin Med; 1978; 18(2):24-8. PubMed ID: 278414
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the treatment of hemoblastoses with N-diethyleneimidophosphonyl-N-phenylurea (C 73)].
    Gerhartz H; Staeuber PG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 83(1):54-61. PubMed ID: 4157882
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental and clinical study of antileukemic activity of N, N'-diethylene-N"-cyclohexyltriamidothiophosphate (hexaphosphamide)].
    Khomchenovskiĭ EI; Nevskaia TP; Cherntsova TA; Susoeva VM
    Probl Gematol Pereliv Krovi; 1968 Oct; 13(10):49-56. PubMed ID: 5259518
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antitumor activity and pharmacological properties of furizil].
    Stukov AN; Kraĭz BO; Aleksandrov VA; Ivin BA; Filov VA
    Vopr Onkol; 1985; 31(5):52-4. PubMed ID: 4013130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study of the toxicity and antitumor activity of halide derivatives of ethyleneimine].
    Demirchoglian IG; Papoian SA; Babasian OV; Galstian DA; Oganesian MS
    Zh Eksp Klin Med; 1976; 16(5):33-8. PubMed ID: 1023706
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of hexaphosphamide on the cellular cycle of mouse lympholeukemia L-1210].
    Egorov LV; Gerasimova NA; Kozinets GI; Zaretskiĭ II
    Probl Gematol Pereliv Krovi; 1976 Mar; 21(3):30-3. PubMed ID: 995892
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitumour activity of some cyclophosphazenes.
    Labarre JF; Faucher JP; Levy G; Sournies F; Cros S; François G
    Eur J Cancer (1965); 1979 May; 15(5):637-43. PubMed ID: 510331
    [No Abstract]   [Full Text] [Related]  

  • 10. The antineoplastic activity of hexaziridinocyclotriphosphazene (Myko 63) in murine tumors.
    Malfiore C; Marmonti L; Filippeschi S; Labarre JF; Spreafico F
    Anticancer Res; 1983; 3(6):425-9. PubMed ID: 6230986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological properties and antitumor activity of a preparation diiodo-benzo-tepa in experiments].
    Trinus FP; Sologub PY; Protsenko LD; Tarnavskaya MI; Nikolaeva SV; Danilenko VS; Sharykina NI; Kolodyazhny VI; Zaikina RG; Goncharenko GV; Kopel'nik MA; Andrianova SM
    Vopr Onkol; 1979; 25(9):53-8. PubMed ID: 90429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.
    Budman DR; Forastiere A; Perloff M; Perry M; Aisner J; Weinberg V; Wood W
    Cancer Treat Rep; 1982 Oct; 66(10):1875-6. PubMed ID: 7127327
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study.
    Shildt R; Stephens RL; Subramanian VP; Baker LH; Fletcher WS; O'Bryan RM; McCracken JD
    Cancer Treat Rep; 1985 Jun; 69(6):709-10. PubMed ID: 4016775
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of the studies of ethyleneiminotriazines].
    Ivin BA; Kraĭz BO; Korsakov MV; Stukov AN; Sheĭman VP; Filov VA
    Vopr Onkol; 1990; 36(1):6-12. PubMed ID: 2407028
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo.
    Johnson RK; Wodinsky I; Swiniarski J; Meaney KF; Clement JJ
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1605-9. PubMed ID: 583418
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antitumor action of new 2,4-diethyleneimino-6-amino-sym.-triazina derivatives].
    Maliugina LL; Pol'kina RI; Kraĭz BO; Remizov AL
    Vopr Onkol; 1977; 23(12):70-5. PubMed ID: 602082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of various antitumor drugs on developing Schwez erythromyelosis in rats].
    Emanuel' NM; Dronova LM; Erokhin VN; Belich EI
    Izv Akad Nauk SSSR Biol; 1970; 1():87-92. PubMed ID: 5275614
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycin.
    Tannock I
    Cancer Res; 1983 May; 43(5):2059-62. PubMed ID: 6831436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of antileukemic agents using transplantable rat leukemia induced by nitrosobutylurea (NBU) (DBLA-lines) as a screening tool: method of treatment of leukemia based on the results in experimental leukemia].
    Himori T; Sugawara N
    Nihon Rinsho; 1972 Apr; 30(4):1051-61. PubMed ID: 4672749
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental and clinical data on the antitumor action of hydrazine sulfate].
    Seĭts IF; Gershanovich ML; Filov VA; Danova LA; Kondrat'ev VB
    Vopr Onkol; 1975; 21(1):45-52. PubMed ID: 1090085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.